Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
BR790 / Jiangxi Qingfeng Pharma
NCT05505877: Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors	Recruiting	1/2	160	RoW	BR790+Tislelizumab	Shanghai Gopherwood Biotech Co., Ltd.	Advanced Solid Tumor	10/24	12/24
NCT05715398: BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer	Not yet recruiting	1/2	90	NA	BR790+anlotinib	Shanghai Gopherwood Biotech Co., Ltd.	Non-Small Cell Lung Cancer	12/24	12/25
NCT04891653: A Phase I Study of BR790 in Subjects With Advanced Solid Tumors	Not yet recruiting	1	48	NA	BR790	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	Advanced Solid Tumor	06/23	12/23